uftoral has been researched along with Cachexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, A; Nakano, K; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Fujioka, A; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
2 other study(ies) available for uftoral and Cachexia
| Article | Year |
|---|---|
Prolongation of survival period and improvement of cancer cachexia by long-term administration of UFT.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Dogs; Drug Administration Schedule; Drug Combinations; Interleukin-6; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Tegafur; Uracil | 1996 |
[Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Colonic Neoplasms; Dinoprostone; Doxorubicin; Drug Combinations; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mitomycin; Survival Analysis; Tegafur; Tumor Cells, Cultured; Uracil | 1996 |